ITMCTR2000003279
Not yet recruiting
Phase 1
A randomized, double-blind, placebo, parallel controlled trial for Pien-Tze-Huang Capsules in treating convalescent novel coronavirus pneumonia (COVID-19) patient with SARS-CoV-2 positive.
Hubei Provincial Hospital of TCM0 sitesTBD
Conditionsovel coronavirus pneumonia (COVID-19)
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- ovel coronavirus pneumonia (COVID-19)
- Sponsor
- Hubei Provincial Hospital of TCM
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients who meet the COVID\-19 diagnostic criteria and discharge standards, but the later SARS\-CoV\-2 virus nucleic acid test is positive;
- •(2\) Aged 18 to 70 years old;
- •(3\) Signed informed consent.
Exclusion Criteria
- •1\. Accompanied by severe basic diseases affecting survival, including uncontrolled clinically significant heart, kidney, digestive, blood diseases, neuropsychiatric diseases, immune diseases, metabolic diseases, malignant tumors, severe malnutrition, etc.;
- •2\. Unstable angina pectoris or myocardial infarction in the last 1 month;
- •3\. Allergic constitution, allergic to the drug ingredients involved in the treatment program;
- •4\. Pregnant or nursing women;
- •5\. Mental state cannot cooperate, suffer from mental illness, have no self\-control, cannot express clearly;
- •6\. Participating in other clinical trials;
- •7\. According to the judgment of the researchers, patients who will be included in the group will have complications or poor compliance, which will affect the efficacy and safety evaluation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
A randomized, parallel, double-blind, placebo controlled trial to investigate HPA-axis activation before and after electro-convulsive therapy in patients with a major depressive episode using an orally administered 5-HTP challenge testdepressiondepressive disorder10027946NL-OMON33643Centre for Human Drug Research30
Completed
Not Applicable
clinical trial for the patients with degenerative disc diseaseDiseases of the musculo-skeletal system and connective tissueKCT0001037Yuhan48
Active, not recruiting
Not Applicable
A randomized, double blind, parallel, placebo controlled, exploratory study to assess the effect of EA-230 on renal function and on safety and tolerability in patients at increased risk of developing renal failure following major cardiac on-pump surgery.EUCTR2007-007132-25-DEEBI Anti Sepsis B.V.150
Completed
Phase 3
A clinical trial to study the effect of the addition of Vitamin D to conventional treatment in new pulmonary tuberculosis patientsCTRI/2007/091/000008Christian Medical College,Vellore250
Active, not recruiting
Not Applicable
A parallel, randomised, double blind, placebo controlled study to investigate the effect of SagaPro on nocturia in meocturiaMedDRA version: 12.1Level: LLTClassification code 10029446Term: NocturiaEUCTR2010-019668-35-ISSagaMedica ehf.